MicroRNA-21 identified as predictor of cancer outcome: A meta-analysis

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Zhu, Wenjie ^a   Xu, Binghe ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 21; MICRORNA; MIRN21 MICRORNA, HUMAN; RNA;

ARTICLE; CANCER PROGNOSIS; COLORECTAL CANCER; DISEASE FREE SURVIVAL; GENE OVEREXPRESSION; HUMAN; LONG TERM SURVIVAL; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; OVERALL SURVIVAL; PANCREAS CANCER; PREDICTIVE VALUE; SURVIVAL PREDICTION; FEMALE; LUNG TUMOR; MALE; META ANALYSIS; METABOLISM; MORTALITY; NON SMALL CELL LUNG CANCER; PANCREAS TUMOR; SURVIVAL RATE;

CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; PANCREATIC NEOPLASMS; RNA, NEOPLASM; SURVIVAL RATE;

EID: 84905510366     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103373     Document Type: Article

References (54)

1. Croce CM, Calin GA (2005) miRNAs, cancer and stem cell division. Cell 122: 6-7. (Pubitemid 40977933)
2. Fabian MR, Sonenberg N (2012) The mechanics of miRNA-mediated gene silencing: A look under the hood of miRISC. Nat Struct Mol Biol 19: 586-593.
3. Ahmad A, Ali AS, Ali S, Wang Z, Kong D, et al (2011) MicroRNAs: Targets of Interest in Breast Cancer Research. In: Mulligan JA, editor. MicroRNA: Expression, Detection and Therapeutic Strategies. Hauppauge: Nova Science Publishers. 59-78.
4. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854. (Pubitemid 24014542)
5. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM (2006) MicroRNA expression and function in cancer. Trends Mol. Med 12: 580-587. (Pubitemid 44780201)
6. Barh D, Malhotra R, Ravi B, Sindhurani P (2010) MicroRNA let-7: An emerging next-generation cancer therapeutic. Curr. Oncol 17: 70-80.
7. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
8. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
9. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773. (Pubitemid 40292988)
10. Zhang B, Pan X, Cobb G, Anderson T (2007) MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12. (Pubitemid 46096921)
11. Manikandan J, Aarthi J, Kumar S, Pushparaj P (2008) Oncomirs: the potential role of non-coding microRNAs in understanding cancer. Bioinformation 2: 330-334.
12. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, et al (2008) MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27: 4373-4379. (Pubitemid 352010003)
13. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, et al (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658. (Pubitemid 47187346)
14. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, et al (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136. (Pubitemid 351485639)
15. Si M, Zhu S, Wu H, Lu Z, Wu F, et al (2007) Mir-21-mediated tumor growth. Oncogene 26: 2799-2803. (Pubitemid 46663837)
16. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033. (Pubitemid 40994386)
17. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, et al (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026-1033.
18. Frezzetti D, De Menna M, Zoppoli P, Guerra C, Ferraro A, et al (2011) Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene 30: 275-286.
19. Medina PP, Nolde M, Slack FJ (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467: 86-90.
20. Yan LX, Wu QN, Zhang Y, Li YY, Liao DZ, et al (2011) Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast Cancer Res 13: R2.
21. Krichevsky AM, Gabriely G (2009) miR-21: a small multi-faceted RNA. J Cell Mol Med 13: 39-53.
22. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261. (Pubitemid 43271657)
23. Wang B, Zhang Q (2012) The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. J Cancer Res Clin Oncol 138: 1659-1666.
24. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, et al (2007) Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120: 1046-1054. (Pubitemid 46214304)
25. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, et al (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-36. (Pubitemid 351185951)
26. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, et al (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14: 2348-2360.
27. Hwang JH, Voortman J, Giovannetti E, Steinberg SM, Leon LG, et al (2010) Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS ONE 5: e10630. Available at: http://www.plosone.org/article/info%3Adoi%2F10. 1371%2Fjournal.pone.0010630. Accessed at 19 December 2013.
28. Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE, et al (2011) Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem 57: 84-91.
29. Liu R (2012) Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 58: 610-618.
30. Gao W, Lu X, Liu L, Xu J, Feng D, et al (2012) MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non small cell lung cancer. Cancer Biol Ther 13: 330-340.
31. Shen J (2011) Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer 11: 374.
32. Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, et al (2007) MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 121: 1156-1161. (Pubitemid 47101656)
33. Childs G, Fazzari M, Kung G, Kawachi N, Brandwein-Gensler M, et al (2009) Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 174: 736-745.
34. Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ (2010) Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist 15: 673-682.
35. Qian B, Katsaros D, Lu L, Preti M, Durando A, et al (2009) High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res Treat 117: 131-140.
36. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al (2000) Metaanalysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012. (Pubitemid 30214957)
37. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17: 2815-2834. (Pubitemid 28562978)
38. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. (Pubitemid 27387172)
39. Zhao Y, Schetter AJ, Yang GB, Nguyen G, Mathé EA, et al (2013) microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma. Int J Cancer 132: 2901-2909.
40. Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, et al (2008) Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RTPCR. Clin Chem 54: 1696-1704.
41. Hirata K, Suzuki H, Imaeda H, Matsuzaki J, Tsugawa H, et al (2013) CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence. Br J Cancer 109: 379-386.
42. Nielsen BS, Jørgensen S, Fog JU, Søkilde R, Christensen IJ, et al (2011) High levels of microRNA-21 in the stroma of colorectal cancers predict short diseasefree survival in stage II colon cancer patients. Clin Exp Metastasis 28: 27-38.
43. Jiang L, Lv X, Li J, Lv M, Jiang P, et al (2012) The status of microRNA-21 expression and its clinical significance in human cutaneous malignant melanoma. Acta Histochemica 114: 582-588.
44. Zhu S, Si ML, Wu H, Mo YY (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-14336. (Pubitemid 47100416)
45. Yang Y, Chaerkady R, Beer MA, Mendell JT, Pandey A (2009) Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach. Proteomics 9: 1374-1384.
46. Song B, Wang C, Liu J, Wang X, Lv L, et al (2010) MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J Exp Clin Cancer Res 29: 29.
47. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, et al (2010) Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18: 282-293.
48. Papagiannakopoulos T, Shapiro A, Kosik KS (2008) MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 68: 8164-8172.
49. Wickramasinghe NS (2009) Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res 37: 2584-2595.
50. Xia X, Yang B, Zhai X, Liu X, Shen K, et al (2013) Prognostic Role of microRNA-21 in Colorectal Cancer: a Meta-Analysis. PLoS ONE 8(11): e80426. doi:10.1371/journal.pone.0080426.
51. Fu X, Han Y, Wu Y, Zhu X, Lu X, et al (2011) Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis. Eur J Clin Invest 41: 1245-1253.
52. Wang Y, Gao X, Wei F, Zhang X, Yu J, et al (2013) Diagnostic and prognostic value of circulating miR-21 for cancer: A systematic review and meta-analysis. Gene 533: 389-397.
53. Xu Y, Xi QH, Ge WL, Zhang XQ (2013) Identification of serum microRNA-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer. Asian Pacific J Cancer Prev 14: 1057-1060.
54. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.